drugset / Trial / NCT06981234
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
RandomizedCrossoverDouble-blindTreatment
Summary
The goal of this study is to learn about the effect of the study drug acetazolamide in individuals with Type 1 Diabetes. Specifically, whether acetazolamide provides benefits to the kidneys while minimizing any side effects of the drug. These changes will be measured by laboratory tests that tell us how well the kidneys are functioning.
Timeline
- Start
- 2024-08-14
- Primary completion
- 2026-12
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetazolamide | Small molecule | 250 mg | — |